Dow Falls Nearly 250 Points On Losses In Shares Of UnitedHealth, Johnson & Johnson

Dow Jones12-17 04:31

DJ Dow Falls Nearly 250 Points On Losses In Shares Of UnitedHealth, Johnson & Johnson

This article was automatically generated by MarketWatch using technology from Automated Insights.

Dragged down by losses for shares of UnitedHealth and Johnson & Johnson, the Dow Jones Industrial Average is falling Tuesday afternoon.

Shares of UnitedHealth (UnitedHealth Group Inc.) and Johnson & Johnson (Johnson & Johnson) have contributed to the index's intraday decline, as the Dow (Dow Jones Industrial Average) was most recently trading 243 points lower (-0.5%).

UnitedHealth's shares are off $8.50, or 2.5%, while those of Johnson & Johnson are off $4.87 (2.3%), combining for an approximately 82-point drag on the Dow.

Also contributing significantly to the decline are Chevron (Chevron Corp.), IBM (International Business Machines Corp.), and Merck (Merck & Co. Inc.).

A $1 move in any one of the 30 components of the index results in a 6.16-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled December 16, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

December 16, 2025 15:31 ET (20:31 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment